With robust business model offering to 5 different markets, we also seek innovation opportunities in universities, research institutions, other biotech and Pharmaceutical companies.
To find out what we can offer you, please click here to contact us.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
30
Jul 2026
A joint research team led by Professor Daesik Kim (Department of Medicine, Sungkyunkwan University), along with Professor Yong-Sub Kim (University of Ulsan College of Medicine) and Professor Jae-Hyun Park (Sungkyunkwan University School of Medicine), has announced the development of 'OpenABE' (Open Adenine Base Editor).
30
Jul 2026
Cardiovascular disease (CVD) is among the leading causes of death worldwide. In South Korea, it is the second leading cause of death, and its incidence has continued to rise in recent years.
30
Jul 2026
When researchers screen potential tuberculosis drugs, they often end up with too many options. Some look promising but later prove to be costly dead ends.
30
Jul 2026
In a promising sign for the potential of focused sound waves to improve care for brain tumors, UVA Health researchers have determined that tumors called gliomas may be even more receptive to targeted drug delivery than normal brain tissue.